{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:20:28Z","timestamp":1791102028010,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.pbb.2013.03.017","type":"journal-article","created":{"date-parts":[[2013,4,9]],"date-time":"2013-04-09T11:03:16Z","timestamp":1365505396000},"page":"20-23","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["Effects of ketamine and LY341495 on the depressive-like behavior of repeated corticosterone-injected rats"],"prefix":"10.1016","volume":"107","author":[{"given":"Hiroyuki","family":"Koike","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michihiko","family":"Iijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeyuki","family":"Chaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2013.03.017_bb0005","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.biopsych.2009.08.038","article-title":"Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression","volume":"67","author":"aan het Rot","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2013.03.017_bb0010","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.neuropharm.2008.08.026","article-title":"Antidepressant-like effects of the glucocorticoid receptor antagonist RU-43044 are associated with changes in prefrontal dopamine in mouse models of depression","volume":"55","author":"Ago","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2013.03.017_bb0020","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0006-3223(99)00159-6","article-title":"Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study","volume":"47","author":"Auer","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2013.03.017_bb0025","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature10130","article-title":"NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses","volume":"475","author":"Autry","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2013.03.017_bb0030","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.neuropharm.2012.05.022","article-title":"mGlu2\/3 and mGlu5 receptors: potential targets for novel antidepressants","volume":"66","author":"Chaki","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2013.03.017_bb0035","doi-asserted-by":"crossref","first-page":"15653","DOI":"10.1073\/pnas.0507901102","article-title":"Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression","volume":"102","author":"Choudary","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pbb.2013.03.017_bb0040","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.4088\/JCP.09m05327blu","article-title":"Rapid resolution of suicidal ideation after a single infusion of an N-methyl-d-aspartate antagonist in patients with treatment-resistant major depressive disorder","volume":"71","author":"DiazGranados","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pbb.2013.03.017_bb0045","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.neuroscience.2005.12.058","article-title":"Antidepressants reverse corticosterone-mediated decrease in brain-derived neurotrophic factor expression: differential regulation of specific exons by antidepressants and corticosterone","volume":"139","author":"Dwivedi","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2013.03.017_bb0050","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1017\/S1461145711001702","article-title":"mTOR activation is required for the antidepressant effects of mGluR2\/3 blockade","volume":"15","author":"Dwyer","year":"2012","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pbb.2013.03.017_bb0055","doi-asserted-by":"crossref","DOI":"10.1002\/0471142301.ns0932s49","article-title":"Recapitulation and reversal of a persistent depression-like syndrome in rodents","author":"Gourley","year":"2009","journal-title":"Curr Protoc Neurosci"},{"key":"10.1016\/j.pbb.2013.03.017_bb0060","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.biopsych.2007.03.017","article-title":"Increased levels of glutamate in brains from patients with mood disorders","volume":"62","author":"Hashimoto","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2013.03.017_bb0065","doi-asserted-by":"crossref","first-page":"e20198","DOI":"10.1371\/journal.pone.0020198","article-title":"Long-term continuous corticosterone treatment decreases VEGF receptor-2 expression in frontal cortex","volume":"6","author":"Howell","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pbb.2013.03.017_bb0070","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.brainres.2010.08.078","article-title":"Pharmacological characterization of repeated corticosterone injection-induced depression model in rats","volume":"1359","author":"Iijima","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2013.03.017_bb0075","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.brainres.2006.06.077","article-title":"Chronic corticosterone decreases brain-derived neurotrophic factor (BDNF) mRNA and protein in the hippocampus, but not in the frontal cortex, of the rat","volume":"1110","author":"Jacobsen","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2013.03.017_bb0080","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.bbr.2005.11.019","article-title":"Effect of different doses of corticosterone on depression-like behavior and HPA axis responses to a novel stressor","volume":"168","author":"Johnson","year":"2006","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2013.03.017_bb0085","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1192\/bjp.bp.108.050278","article-title":"Prednisolone suppression test in depression: prospective study of the role of HPA axis dysfunction in treatment resistance","volume":"194","author":"Juruena","year":"2009","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pbb.2013.03.017_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0028-3908(97)00191-3","article-title":"LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors","volume":"37","author":"Kingston","year":"1998","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2013.03.017_bb0095","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bbr.2011.05.035","article-title":"Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression","volume":"224","author":"Koike","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2013.03.017_bb0100","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.neuropharm.2011.08.034","article-title":"Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists","volume":"61","author":"Koike","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2013.03.017_bb0105","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbr.2012.10.023","article-title":"Role of BDNF\/TrkB signaling in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist in animal models of depression","volume":"238","author":"Koike","year":"2013","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2013.03.017_bb0110","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.pbb.2013.03.017_bb0115","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.biopsych.2010.12.015","article-title":"Glutamate N-methyl-d-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure","volume":"69","author":"Li","year":"2011","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2013.03.017_bb0120","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1073\/pnas.0706679105","article-title":"Stress blunts serotonin- and hypocretin-evoked EPSCs in prefrontal cortex: role of corticosterone-mediated apical dendritic atrophy","volume":"105","author":"Liu","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pbb.2013.03.017_bb0125","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.biopsych.2011.09.030","article-title":"Brain-derived neurotrophic factor Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex","volume":"71","author":"Liu","year":"2012","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2013.03.017_bb0130","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.pnpbp.2006.03.036","article-title":"Correlation between plasma levels of glutamate, alanine and serine with severity of depression","volume":"30","author":"Mitani","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pbb.2013.03.017_bb0135","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jchemneu.2009.05.009","article-title":"Morphological reorganization after repeated corticosterone administration in the hippocampus, nucleus accumbens and amygdala in the rat","volume":"38","author":"Morales-Medina","year":"2009","journal-title":"J Chem Neuroanat"},{"key":"10.1016\/j.pbb.2013.03.017_bb0140","first-page":"121","article-title":"Response to steroid suppression in major depression resistant to antidepressant therapy","volume":"11","author":"Murphy","year":"1991","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pbb.2013.03.017_bb0145","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.neulet.2004.09.035","article-title":"The NR1 subunit of the glutamate\/NMDA receptor in the superior temporal cortex in schizophrenia and affective disorders","volume":"372","author":"Nudmamud-Thanoi","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pbb.2013.03.017_bb0150","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0925-4927(03)00003-9","article-title":"Effective electroconvulsive therapy reverses glutamate\/glutamine deficit in the left anterior cingulum of unipolar depressed patients","volume":"122","author":"Pfleiderer","year":"2003","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pbb.2013.03.017_bb0155","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.biopsych.2009.04.029","article-title":"Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression","volume":"66","author":"Price","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2013.03.017_bb0160","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1001\/archpsyc.61.7.705","article-title":"Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression","volume":"61","author":"Sanacora","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pbb.2013.03.017_bb0165","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.pnpbp.2010.03.005","article-title":"Behavioral and neurobiological consequences of prolonged glucocorticoid exposure in rats: relevance to depression","volume":"34","author":"Sterner","year":"2010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pbb.2013.03.017_bb0170","first-page":"S166","article-title":"Further evidence for a metabotropic glutamate group II antagonist mechanism for the induction of antidepressant-like effects in rodents","author":"Witkin","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2013.03.017_bb0175","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00213-006-0390-7","article-title":"An mGluR2\/3 antagonist, MGS0039, exerts antidepressant and anxiolytic effects in behavioral models in rats","volume":"186","author":"Yoshimizu","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2013.03.017_bb0180","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pbb.2013.03.017_bb0185","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.biopsych.2011.12.010","article-title":"Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial","volume":"71","author":"Zarate","year":"2012","journal-title":"Biol Psychiatry"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009130571300083X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009130571300083X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T03:01:11Z","timestamp":1539745271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009130571300083X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":36,"alternative-id":["S009130571300083X"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2013.03.017","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}